1. Home
  2. KALV vs GPOR Comparison

KALV vs GPOR Comparison

Compare KALV & GPOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$17.00

Market Cap

551.2M

Sector

Health Care

ML Signal

HOLD

Logo Gulfport Energy Corporation

GPOR

Gulfport Energy Corporation

HOLD

Current Price

$207.98

Market Cap

4.1B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
GPOR
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
551.2M
4.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KALV
GPOR
Price
$17.00
$207.98
Analyst Decision
Strong Buy
Buy
Analyst Count
8
10
Target Price
$26.43
$225.67
AVG Volume (30 Days)
1.6M
248.8K
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,426,000.00
$1,231,668,000.00
Revenue This Year
N/A
$57.17
Revenue Next Year
$204.16
$8.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
38.91
52 Week Low
$7.30
$153.27
52 Week High
$17.28
$225.78

Technical Indicators

Market Signals
Indicator
KALV
GPOR
Relative Strength Index (RSI) 70.46 50.59
Support Level $15.88 $203.00
Resistance Level $17.10 $222.87
Average True Range (ATR) 1.08 6.40
MACD 0.22 -2.11
Stochastic Oscillator 96.52 26.92

Price Performance

Historical Comparison
KALV
GPOR

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About GPOR Gulfport Energy Corporation

Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets predominantly located in the Appalachia and Anadarko basins in the United States. Its principal properties are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.

Share on Social Networks: